Clinical Trials on Prosthetic Cardiac Valve Thrombosis in Switzerland

Total 17 results

University Hospital, Basel, Switzerland

Completed

Patient Outcome After Cardiac Double Valve Replacement at University Hospital Basel/ Switzerland

Cardiac Double Valve Replacement

Switzerland
University Hospital Inselspital, Berne

Terminated

Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve. (CATHAR)

Aortic Valve Disease | Anticoagulants | Heart Valve Prosthesis Implantation

Switzerland
University Hospital Inselspital, Berne

Completed

Assessment of Arrhythmias in Patients Undergoing Transcatheter Aortic Valve Implantation Using a Small Insertable Cardiac Monitoring Device (Reveal)

Aortic Valve Stenosis

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (Co-STAR)

Transcatheter Aortic Valve Replacement | Atrial Fibrillation New Onset | Pacemaker | Colchicine

Switzerland
University of Zurich
Abbott Medical Devices

Active, not recruiting

Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI (TAVI/LAAO)

Atrial Fibrillation | Aortic Stenosis

Switzerland
ECRI bv
Bayer; Rigshospitalet, Denmark; Cardialysis BV

Completed

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) (GALILEO-4D)

Cardiovascular Diseases | Thrombosis | Aortic Valve Stenosis | Heart Valve Diseases | Ventricular Outflow Obstruction

Germany, United States, Denmark, Switzerland, Netherlands, Sweden, Canada
University Hospital, Basel, Switzerland
University of Basel

Completed

Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

Switzerland
Biosensors Europe SA
European Cardiovascular Research Center

Completed

Leaders Free III: BioFreedom™ Clinical Trial

Myocardial Infarction | Mortality | Bleeding | Cardiac Death | Stent Thrombosis

France, Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

ATTR Amyloidosis in Elderly Patients With Aortic Stenosis

Aortic Stenosis Symptomatic | Amyloidosis Cardiac

Switzerland
University Hospital Inselspital, Berne

Recruiting

LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Cardiovascular Diseases | Atrial Fibrillation | Thromboembolism

Switzerland
Corcym S.r.l

Recruiting

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting (MANTRA)

Cardiac Valve Disease

United States, Belgium, Korea, Republic of, Germany, Italy, Switzerland, United Kingdom, France, Austria, Canada, Netherlands, Portugal, Serbia
Groupe Hospitalier de la Rochelle Ré Aunis
Diagnostica Stago

Completed

Exclusion of Intra-atrial Thrombus Before Catheter Ablation (EXTRALUCID)

Atrial Fibrillation | Thrombi

France, Switzerland
Cantonal Hospital of St. Gallen

Completed

Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon

Atrial Fibrillation | Pulmonary Embolism | Hip Replacement Postoperative | Knee Replacement Postoperative

Switzerland
Population Health Research Institute
Bristol-Myers Squibb; Pfizer; Canadian Institutes of Health Research (CIHR); Me...

Completed

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA)

Stroke | Atrial Fibrillation

United States, Spain, Canada, Belgium, United Kingdom, Denmark, Germany, Switzerland, Netherlands, Hungary, Norway, Czechia, Italy
Daiichi Sankyo, Inc.
The TIMI Study Group

Completed

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation (EngageAFTIMI48)

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Italy, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, India, Romania, Russian Federation, Serbia, South Africa, Turkey, Korea, Republic of and more
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Poland, Ukraine, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Colombia, Israel, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic... and more
Bayer

Terminated

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke (OCEANIC-AF)

Atrial Fibrillation | Prevention of Stroke or Systemic Embolism

Canada, United States, Israel, Korea, Republic of, China, Taiwan, Belgium, Australia, Singapore, Malaysia, Slovakia, United Kingdom, Czechia, Latvia, Japan, Brazil, Lithuania, Germany, France, Sweden, Turkey, Switzerland, Estonia, Bul... and more

Clinical Trials on Prosthetic Cardiac Valve Thrombosis in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations